Natriuretic peptides as regulators of myocardial structure and function: pathophysiologic and therapeutic implications.
Cataliotti
Alessandro
A
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55904, USA. cataliotti.alessandro@mayo.edu
Chen
Horng H
HH
Redfield
Margaret M
MM
Burnett
John C
JC
D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000503:physiopathology*; D005347:Fibroblasts / Q000502:physiology; D006321:Heart / Q000503:physiopathology*; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000502:physiology; D045265:Natriuretic Peptides / Q000502:physiology* / Q000627:therapeutic use
D045265:Natriuretic Peptides